Skip to content

Clinical trials

Phase 1 Hyperlipidemias trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperlipidemias Phase: Phase 1 Country / region: South Korea Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20114
20121
20133
20142
20155
20166
20173
20185
20191
20201
20223
20231
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Not yet recruiting2
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Addpharma Inc.6
Chong Kun Dang Pharmaceutical6
Jeil Pharmaceutical Co., Ltd.5
Boryung Pharmaceutical Co., Ltd4
Yuhan Corporation4
HK inno.N Corporation2
JW Pharmaceutical2
LG Life Sciences2
Alvogen Korea1
DongKoo Bio & Pharma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperlipidemias37
Hypertension21
Diabetes Mellitus4
Essential Hypertension2
Arteriosclerosis1
Diabetes Mellitus, Type 21
Hypercholesterolemia1
Hypertriglyceridemia1

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.